For the Inventor, By the Inventor

Enter assignee name

Auckland, New Zealand

Genesis Research & Development Corporation Limited

USPTO Granted Patents = 26

% Expired Patents = 19.2

CIPO Patents = 1

Forward Citations = 179

Loading Chart...

Loading Chart...

23 inventors (with patents filed for the assignee):

James Douglas Watson (7 out of 21 patents)

Ross L Prestidge (6 out of 10 patents)

Alain Delcayre (6 out of 14 patents)

4. Paul L Tan (6 out of 6 patents)

5. Elizabeth Visser (3 out of 7 patents)

6. Matthew Sleeman (3 out of 3 patents)

7. Nevin Abernethy (3 out of 3 patents)

8. Paul L J Tan (3 out of 3 patents)

9. Lorna Strachan (3 out of 3 patents)

10. Jun Hiyama (3 out of 3 patents)

11. Leonard N Bloksberg (2 out of 17 patents)

12. Ilkka Havukkala (2 out of 14 patents)

13. James Greg Murison (2 out of 2 patents)

14. Timothy Strabala (2 out of 2 patents)

15. Nicolaas J Nieuwenhuizen (2 out of 2 patents)

Core Competencies:

Infectious Diseases

Immune System Disorders

Mycobacterium Vaccae

Fibroblast Growth Factor

Plant Cell Signaling

Polynucleotides

Polypeptides

Immunologically-Mediated Diseases

Mycobacterial Infections

Lignin Modification

Skin Disorders

Antigens

26 patents: Sort by Forward Citations

1. 7192590 - Compounds for treatment of infectious and immune system disorders and methods for their use (2007-03-20),

2. 7083791 - Methods for enhancing immune responses by fibroblast growth factor receptor 5 polypeptides (2006-08-01),

3. 7041295 - Compounds for treatment of infectious and immune system disorders and methods for their use (2006-05-09),

4. 6797271 - Methods for enhancing immune responses by fibroblast growth factor receptor 5 polypeptides (2004-09-28),

5. 6768041 - Compositions isolated from plant cells and their use in the modification of plant cell signaling (2004-07-27),

6. 6723327 - Methods and compounds for the treatment of immunologically-mediated diseases using mycobacterium vaccae (2004-04-20),

7. 6716430 - Compositions isolated from M. vaccae and their use in the modulation of immune responses (2004-04-06),

8. 6573095 - Polynucleotides isolated from skin cells (2003-06-03),

9. 6436898 - Compounds for treatment of infectious and immune system disorders and methods for their use (2002-08-20),

10. 6410720 - Compounds and methods for treatment and diagnosis of mycobacterial infections (2002-06-25),

11. 6406704 - Compounds and methods for treatment and diagnosis of mycobacterial infections (2002-06-18),

12. 6380362 - Polynucleotides, polypeptides expressed by the polynucleotides and methods for their use (2002-04-30),

13. 6361776 - Compounds isolated from M. vaccae and their use in modulation of immune responses (2002-03-26),

14. 6359198 - Compositions isolated from plant cells and their use in the modification (2002-03-19),

15. 6358734 - Compounds for treatment of infectious and immune system disorders and methods for their use (2002-03-19),

Company Overview

Genesis Research & Development Corporation Limited is a biotechnology firm based in Auckland, New Zealand, specializing in the development of innovative agricultural solutions. The company focuses on enhancing crop performance and sustainability through advanced research in plant genetics and biotechnology. By leveraging cutting-edge technologies, Genesis aims to address global agricultural challenges, contributing to food security and environmental sustainability while fostering growth in the agricultural sector.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 13 2026

26 Patents

#14 in Auckland

#26 in New Zealand

#24,806 in the World

Auckland, New Zealand

Genesis Research & Development Corporation Limited

Forward Citations = 179

23 inventors:

James Douglas Watson (7 out of 21 patents)

Ross L Prestidge (6 out of 10 patents)

Alain Delcayre (6 out of 14 patents)

4. Paul L Tan (6 out of 6 patents)

5. Elizabeth Visser (3 out of 7 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Genesis Research & Development Corporation Limited. Retrieved from https://idiyas.com/company/genesis-research-and-development

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

Loading…